Global Dental Drug Market research

Dental Drug Comprehensive Study by Type (Injectable, Oral, Spray), Application (Drug stores, Retail pharmacies, Hospital pharmacies, Online stores) Players and Region - Global Market Outlook to 2026

Dental Drug Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Dental Drug Market Overview:
Dental drug are medications to fight against oral disease in order to control pain, prevent or treat infections and relieve anxiety. These drugs include pain killers, anesthetics, fluoride, antibiotics and others. The use of dental drugs depends on patients overall health. With rising geriatric population across the world, the demand for dental drugs is expected to increase during forecast period.

Growth Drivers
  • Growth in Per Capita Dental Expenditure
  • High Awareness About Dental Care in Developed Countries
  • Rising Geriatric Population

Market Trends
  • Implementation of High-End Imaging and Radiology Devices in Dentistry
  • Growing Emphasizing on Developing Cost-effective Drug Solution

Roadblocks
  • High Cost of Dental Drugs
  • Availability of Counterfeit and Low Cost Drugs

Opportunities
  • Technological Advancement in Dental Drugs
  • Rising Awareness About Oral Care in Emerging Countries

Challenges
  • Unfavorable Dental Reimbursement Rate in the United States
  • Lack of Dental Experts


Competitive Landscape:

Some of the key players profiled in the report are Merck [United States], Bayer [Germany], J&J [United States], GSK [United Kingdom], 3M [United States], Sunstar [Japan], Colgate-Palmolive [United States], DenMat [United States], Danaher Corporation [United States], Kavo Dental Gmbh [Germany] and Sirona Dental Systems Inc [Germany]. Additionally, following companies can also be profiled that are part of our coverage like Septodont [France], Roche Holding AG [Switzerland], Chi-Med [Hong Kong], Pfizer Deutschland GmbH [Germany], AstraZeneca [United Kingdom], Xttrium Laboratories, Inc. [United States] and Hospira [United States]. Analyst at AMA Research see United States Players to retain maximum share of Global Dental Drug market by 2026.

FDA is responsible for protecting public health by making sure the safety, efficacy and security of human drugs. The agency mandates proper labeling of drugs with specific purpose prescribed over it. Failure to adhere to FDA’s guidelines may result in strictest punishment for respective firm.

What Can be Explored with the Dental Drug Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Dental Drug Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Dental Drug
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Dental Drug market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Dental Drug market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Dental Drugs Manufactures, Healthcare Industry, Potential Investors, Research Institutes, Government Agencies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Injectable
  • Oral
  • Spray
By Application
  • Drug stores
  • Retail pharmacies
  • Hospital pharmacies
  • Online stores
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Per Capita Dental Expenditure
      • 3.2.2. High Awareness About Dental Care in Developed Countries
      • 3.2.3. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Unfavorable Dental Reimbursement Rate in the United States
      • 3.3.2. Lack of Dental Experts
    • 3.4. Market Trends
      • 3.4.1. Implementation of High-End Imaging and Radiology Devices in Dentistry
      • 3.4.2. Growing Emphasizing on Developing Cost-effective Drug Solution
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dental Drug, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Dental Drug (Value)
      • 5.2.1. Global Dental Drug by: Type (Value)
        • 5.2.1.1. Injectable
        • 5.2.1.2. Oral
        • 5.2.1.3. Spray
      • 5.2.2. Global Dental Drug by: Application (Value)
        • 5.2.2.1. Drug stores
        • 5.2.2.2. Retail pharmacies
        • 5.2.2.3. Hospital pharmacies
        • 5.2.2.4. Online stores
      • 5.2.3. Global Dental Drug Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Dental Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck [United States]
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer [Germany]
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. J&J [United States]
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GSK [United Kingdom]
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. 3M [United States]
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sunstar [Japan]
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Colgate-Palmolive [United States]
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DenMat [United States]
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danaher Corporation [United States]
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kavo Dental Gmbh [Germany]
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Sirona Dental Systems Inc [Germany]
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Dental Drug Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Dental Drug (Value)
      • 7.2.1. Global Dental Drug by: Type (Value)
        • 7.2.1.1. Injectable
        • 7.2.1.2. Oral
        • 7.2.1.3. Spray
      • 7.2.2. Global Dental Drug by: Application (Value)
        • 7.2.2.1. Drug stores
        • 7.2.2.2. Retail pharmacies
        • 7.2.2.3. Hospital pharmacies
        • 7.2.2.4. Online stores
      • 7.2.3. Global Dental Drug Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dental Drug: by Type(USD Million)
  • Table 2. Dental Drug Injectable , by Region USD Million (2015-2020)
  • Table 3. Dental Drug Oral , by Region USD Million (2015-2020)
  • Table 4. Dental Drug Spray , by Region USD Million (2015-2020)
  • Table 5. Dental Drug: by Application(USD Million)
  • Table 6. Dental Drug Drug stores , by Region USD Million (2015-2020)
  • Table 7. Dental Drug Retail pharmacies , by Region USD Million (2015-2020)
  • Table 8. Dental Drug Hospital pharmacies , by Region USD Million (2015-2020)
  • Table 9. Dental Drug Online stores , by Region USD Million (2015-2020)
  • Table 10. South America Dental Drug, by Country USD Million (2015-2020)
  • Table 11. South America Dental Drug, by Type USD Million (2015-2020)
  • Table 12. South America Dental Drug, by Application USD Million (2015-2020)
  • Table 13. Brazil Dental Drug, by Type USD Million (2015-2020)
  • Table 14. Brazil Dental Drug, by Application USD Million (2015-2020)
  • Table 15. Argentina Dental Drug, by Type USD Million (2015-2020)
  • Table 16. Argentina Dental Drug, by Application USD Million (2015-2020)
  • Table 17. Rest of South America Dental Drug, by Type USD Million (2015-2020)
  • Table 18. Rest of South America Dental Drug, by Application USD Million (2015-2020)
  • Table 19. Asia Pacific Dental Drug, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Dental Drug, by Type USD Million (2015-2020)
  • Table 21. Asia Pacific Dental Drug, by Application USD Million (2015-2020)
  • Table 22. China Dental Drug, by Type USD Million (2015-2020)
  • Table 23. China Dental Drug, by Application USD Million (2015-2020)
  • Table 24. Japan Dental Drug, by Type USD Million (2015-2020)
  • Table 25. Japan Dental Drug, by Application USD Million (2015-2020)
  • Table 26. India Dental Drug, by Type USD Million (2015-2020)
  • Table 27. India Dental Drug, by Application USD Million (2015-2020)
  • Table 28. South Korea Dental Drug, by Type USD Million (2015-2020)
  • Table 29. South Korea Dental Drug, by Application USD Million (2015-2020)
  • Table 30. Taiwan Dental Drug, by Type USD Million (2015-2020)
  • Table 31. Taiwan Dental Drug, by Application USD Million (2015-2020)
  • Table 32. Australia Dental Drug, by Type USD Million (2015-2020)
  • Table 33. Australia Dental Drug, by Application USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Dental Drug, by Type USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Dental Drug, by Application USD Million (2015-2020)
  • Table 36. Europe Dental Drug, by Country USD Million (2015-2020)
  • Table 37. Europe Dental Drug, by Type USD Million (2015-2020)
  • Table 38. Europe Dental Drug, by Application USD Million (2015-2020)
  • Table 39. Germany Dental Drug, by Type USD Million (2015-2020)
  • Table 40. Germany Dental Drug, by Application USD Million (2015-2020)
  • Table 41. France Dental Drug, by Type USD Million (2015-2020)
  • Table 42. France Dental Drug, by Application USD Million (2015-2020)
  • Table 43. Italy Dental Drug, by Type USD Million (2015-2020)
  • Table 44. Italy Dental Drug, by Application USD Million (2015-2020)
  • Table 45. United Kingdom Dental Drug, by Type USD Million (2015-2020)
  • Table 46. United Kingdom Dental Drug, by Application USD Million (2015-2020)
  • Table 47. Netherlands Dental Drug, by Type USD Million (2015-2020)
  • Table 48. Netherlands Dental Drug, by Application USD Million (2015-2020)
  • Table 49. Rest of Europe Dental Drug, by Type USD Million (2015-2020)
  • Table 50. Rest of Europe Dental Drug, by Application USD Million (2015-2020)
  • Table 51. MEA Dental Drug, by Country USD Million (2015-2020)
  • Table 52. MEA Dental Drug, by Type USD Million (2015-2020)
  • Table 53. MEA Dental Drug, by Application USD Million (2015-2020)
  • Table 54. Middle East Dental Drug, by Type USD Million (2015-2020)
  • Table 55. Middle East Dental Drug, by Application USD Million (2015-2020)
  • Table 56. Africa Dental Drug, by Type USD Million (2015-2020)
  • Table 57. Africa Dental Drug, by Application USD Million (2015-2020)
  • Table 58. North America Dental Drug, by Country USD Million (2015-2020)
  • Table 59. North America Dental Drug, by Type USD Million (2015-2020)
  • Table 60. North America Dental Drug, by Application USD Million (2015-2020)
  • Table 61. United States Dental Drug, by Type USD Million (2015-2020)
  • Table 62. United States Dental Drug, by Application USD Million (2015-2020)
  • Table 63. Canada Dental Drug, by Type USD Million (2015-2020)
  • Table 64. Canada Dental Drug, by Application USD Million (2015-2020)
  • Table 65. Mexico Dental Drug, by Type USD Million (2015-2020)
  • Table 66. Mexico Dental Drug, by Application USD Million (2015-2020)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Dental Drug: by Type(USD Million)
  • Table 79. Dental Drug Injectable , by Region USD Million (2021-2026)
  • Table 80. Dental Drug Oral , by Region USD Million (2021-2026)
  • Table 81. Dental Drug Spray , by Region USD Million (2021-2026)
  • Table 82. Dental Drug: by Application(USD Million)
  • Table 83. Dental Drug Drug stores , by Region USD Million (2021-2026)
  • Table 84. Dental Drug Retail pharmacies , by Region USD Million (2021-2026)
  • Table 85. Dental Drug Hospital pharmacies , by Region USD Million (2021-2026)
  • Table 86. Dental Drug Online stores , by Region USD Million (2021-2026)
  • Table 87. South America Dental Drug, by Country USD Million (2021-2026)
  • Table 88. South America Dental Drug, by Type USD Million (2021-2026)
  • Table 89. South America Dental Drug, by Application USD Million (2021-2026)
  • Table 90. Brazil Dental Drug, by Type USD Million (2021-2026)
  • Table 91. Brazil Dental Drug, by Application USD Million (2021-2026)
  • Table 92. Argentina Dental Drug, by Type USD Million (2021-2026)
  • Table 93. Argentina Dental Drug, by Application USD Million (2021-2026)
  • Table 94. Rest of South America Dental Drug, by Type USD Million (2021-2026)
  • Table 95. Rest of South America Dental Drug, by Application USD Million (2021-2026)
  • Table 96. Asia Pacific Dental Drug, by Country USD Million (2021-2026)
  • Table 97. Asia Pacific Dental Drug, by Type USD Million (2021-2026)
  • Table 98. Asia Pacific Dental Drug, by Application USD Million (2021-2026)
  • Table 99. China Dental Drug, by Type USD Million (2021-2026)
  • Table 100. China Dental Drug, by Application USD Million (2021-2026)
  • Table 101. Japan Dental Drug, by Type USD Million (2021-2026)
  • Table 102. Japan Dental Drug, by Application USD Million (2021-2026)
  • Table 103. India Dental Drug, by Type USD Million (2021-2026)
  • Table 104. India Dental Drug, by Application USD Million (2021-2026)
  • Table 105. South Korea Dental Drug, by Type USD Million (2021-2026)
  • Table 106. South Korea Dental Drug, by Application USD Million (2021-2026)
  • Table 107. Taiwan Dental Drug, by Type USD Million (2021-2026)
  • Table 108. Taiwan Dental Drug, by Application USD Million (2021-2026)
  • Table 109. Australia Dental Drug, by Type USD Million (2021-2026)
  • Table 110. Australia Dental Drug, by Application USD Million (2021-2026)
  • Table 111. Rest of Asia-Pacific Dental Drug, by Type USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Dental Drug, by Application USD Million (2021-2026)
  • Table 113. Europe Dental Drug, by Country USD Million (2021-2026)
  • Table 114. Europe Dental Drug, by Type USD Million (2021-2026)
  • Table 115. Europe Dental Drug, by Application USD Million (2021-2026)
  • Table 116. Germany Dental Drug, by Type USD Million (2021-2026)
  • Table 117. Germany Dental Drug, by Application USD Million (2021-2026)
  • Table 118. France Dental Drug, by Type USD Million (2021-2026)
  • Table 119. France Dental Drug, by Application USD Million (2021-2026)
  • Table 120. Italy Dental Drug, by Type USD Million (2021-2026)
  • Table 121. Italy Dental Drug, by Application USD Million (2021-2026)
  • Table 122. United Kingdom Dental Drug, by Type USD Million (2021-2026)
  • Table 123. United Kingdom Dental Drug, by Application USD Million (2021-2026)
  • Table 124. Netherlands Dental Drug, by Type USD Million (2021-2026)
  • Table 125. Netherlands Dental Drug, by Application USD Million (2021-2026)
  • Table 126. Rest of Europe Dental Drug, by Type USD Million (2021-2026)
  • Table 127. Rest of Europe Dental Drug, by Application USD Million (2021-2026)
  • Table 128. MEA Dental Drug, by Country USD Million (2021-2026)
  • Table 129. MEA Dental Drug, by Type USD Million (2021-2026)
  • Table 130. MEA Dental Drug, by Application USD Million (2021-2026)
  • Table 131. Middle East Dental Drug, by Type USD Million (2021-2026)
  • Table 132. Middle East Dental Drug, by Application USD Million (2021-2026)
  • Table 133. Africa Dental Drug, by Type USD Million (2021-2026)
  • Table 134. Africa Dental Drug, by Application USD Million (2021-2026)
  • Table 135. North America Dental Drug, by Country USD Million (2021-2026)
  • Table 136. North America Dental Drug, by Type USD Million (2021-2026)
  • Table 137. North America Dental Drug, by Application USD Million (2021-2026)
  • Table 138. United States Dental Drug, by Type USD Million (2021-2026)
  • Table 139. United States Dental Drug, by Application USD Million (2021-2026)
  • Table 140. Canada Dental Drug, by Type USD Million (2021-2026)
  • Table 141. Canada Dental Drug, by Application USD Million (2021-2026)
  • Table 142. Mexico Dental Drug, by Type USD Million (2021-2026)
  • Table 143. Mexico Dental Drug, by Application USD Million (2021-2026)
  • Table 144. Research Programs/Design for This Report
  • Table 145. Key Data Information from Secondary Sources
  • Table 146. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dental Drug: by Type USD Million (2015-2020)
  • Figure 5. Global Dental Drug: by Application USD Million (2015-2020)
  • Figure 6. South America Dental Drug Share (%), by Country
  • Figure 7. Asia Pacific Dental Drug Share (%), by Country
  • Figure 8. Europe Dental Drug Share (%), by Country
  • Figure 9. MEA Dental Drug Share (%), by Country
  • Figure 10. North America Dental Drug Share (%), by Country
  • Figure 11. Global Dental Drug share by Players 2020 (%)
  • Figure 12. Global Dental Drug share by Players (Top 3) 2020(%)
  • Figure 13. Global Dental Drug share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Merck [United States] Revenue, Net Income and Gross profit
  • Figure 16. Merck [United States] Revenue: by Geography 2020
  • Figure 17. Bayer [Germany] Revenue, Net Income and Gross profit
  • Figure 18. Bayer [Germany] Revenue: by Geography 2020
  • Figure 19. J&J [United States] Revenue, Net Income and Gross profit
  • Figure 20. J&J [United States] Revenue: by Geography 2020
  • Figure 21. GSK [United Kingdom] Revenue, Net Income and Gross profit
  • Figure 22. GSK [United Kingdom] Revenue: by Geography 2020
  • Figure 23. 3M [United States] Revenue, Net Income and Gross profit
  • Figure 24. 3M [United States] Revenue: by Geography 2020
  • Figure 25. Sunstar [Japan] Revenue, Net Income and Gross profit
  • Figure 26. Sunstar [Japan] Revenue: by Geography 2020
  • Figure 27. Colgate-Palmolive [United States] Revenue, Net Income and Gross profit
  • Figure 28. Colgate-Palmolive [United States] Revenue: by Geography 2020
  • Figure 29. DenMat [United States] Revenue, Net Income and Gross profit
  • Figure 30. DenMat [United States] Revenue: by Geography 2020
  • Figure 31. Danaher Corporation [United States] Revenue, Net Income and Gross profit
  • Figure 32. Danaher Corporation [United States] Revenue: by Geography 2020
  • Figure 33. Kavo Dental Gmbh [Germany] Revenue, Net Income and Gross profit
  • Figure 34. Kavo Dental Gmbh [Germany] Revenue: by Geography 2020
  • Figure 35. Sirona Dental Systems Inc [Germany] Revenue, Net Income and Gross profit
  • Figure 36. Sirona Dental Systems Inc [Germany] Revenue: by Geography 2020
  • Figure 37. Global Dental Drug: by Type USD Million (2021-2026)
  • Figure 38. Global Dental Drug: by Application USD Million (2021-2026)
  • Figure 39. South America Dental Drug Share (%), by Country
  • Figure 40. Asia Pacific Dental Drug Share (%), by Country
  • Figure 41. Europe Dental Drug Share (%), by Country
  • Figure 42. MEA Dental Drug Share (%), by Country
  • Figure 43. North America Dental Drug Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck [United States]
  • Bayer [Germany]
  • J&J [United States]
  • GSK [United Kingdom]
  • 3M [United States]
  • Sunstar [Japan]
  • Colgate-Palmolive [United States]
  • DenMat [United States]
  • Danaher Corporation [United States]
  • Kavo Dental Gmbh [Germany]
  • Sirona Dental Systems Inc [Germany]
Additional players considered in the study are as follows:
Septodont [France] , Roche Holding AG [Switzerland] , Chi-Med [Hong Kong] , Pfizer Deutschland GmbH [Germany] , AstraZeneca [United Kingdom] , Xttrium Laboratories, Inc. [United States] , Hospira [United States]
Select User Access Type

Key Highlights of Report


Jan 2021 214 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dental Drug Market research Quantitative research analysis
Global Dental Drug Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Dental Drug Market research Report?

Have a Query? Click Here

Other Related Reports

Prostate Cancer Diagnostics Comprehensive Study by Type (Tumor Biomarker Tests, Imaging, Biopsy, Other), Treatment (Surveillance, Localized Therapy, Systemic Therapy, Others), Test Type (Preliminary ...
$ 3750
Brain Aneurysm Treatment Comprehensive Study by Type (Surgical Clipping, Endovascular Coiling, Flow diverters), Application (Hospitals, Clinics), Type (Unruptured Aneurysm, Ruptured Aneurysm) Players...
$ 3500
Membrane Filtration Systems Comprehensive Study by Type (Microfiltration (MF), Ultrafiltration (UF), Nanofiltration (NF), Reverse Osmosis (RO)), Application (Industrial Water And Wastewater Treatment...
$ 3450
Onychomycosis Comprehensive Study by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis), Application (Children, Male Adult...
$ 3650
Sports Medicine Products Comprehensive Study by Type (Body reconstruction products, Body support & recovery products, Medical accessories), Application (Shoulder injuries, Foot and ankle injuries, El...
$ 3750
Tuberculin Comprehensive Study by Type (PPD-S, PPD RT23, Others), Application (Human Use, Animal Use), Therapy (First-Line Therapy, Second-Line Therapy) Players and Region - Global Market Outlook to ...
$ 3500